JAN 25, 2022 7:00 AM PST

AI Platform Finds Superbugs Faster

WRITTEN BY: Tara Fernandes

In 1945, Sir Alexander Fleming (the microbiologist who discovered the world's first broadly effective antibiotic substance, penicillin) penned a letter to the New York Times. In it, he warned of a future where the overuse and misuse of penicillin could eventually lead to antibiotic-resistant microbes gaining the upper hand. 

“I hope this evil can be averted,” wrote Fleming.

Sadly, seven decades on and this ‘evil’ has the world in a death grip. Antibiotic resistance is one of the three greatest threats to human health. In the 50s, just over 10 percent of Staphylococcus aureus infections were found to be resistant to penicillin. Today, the antibiotic is no longer considered a first line treatment as it only works in under 10 percent of cases.

This is just one of many drug-resistant bacteria that are rapidly spreading worldwide and claiming lives. One of the key challenges in spotting one of these “superbugs” is the speed of the conventional diagnostic process. Lab tests take a few days to grow the bacteria from a patient sample, identify it and find its weak spots, or what (if any) antibiotic treatments would be optimal for treating the infection.

In the meantime, patients are often extremely ill, so doctors may administer a course of broad-spectrum antibiotics (strong medications that can eliminate a range of bacterial classes) as a temporary solution. Here, diagnostic speed can make a big difference—understanding the nature of the bacteria can help guide more targeted, effective treatments to resolve the infection quickly.

“The time taken to optimize antibiotic therapy might mean the difference between life and death if an infection is serious,” explained clinical bacteriologist Adrian Egli from the University Hospital Basel.

Egli and colleagues have brought forward a new AI-powered innovation, capable of slashing diagnostic times by 24 hours. The team’s technique uses mass spectrometry (an instrument for analyzing protein fragments) to create a profile of the offending bacteria from a patient sample. This method only requires the bacteria to be cultured for a few hours, as opposed to a few days for conventional assays.

The study was featured in Nature Medicine.

The team then began training artificial intelligence algorithms with a dataset of over 300,000 bacterial protein profiles collected from diagnostic laboratories. They used this to build a refined, publicly available dataset featuring 800 bacterial species and how they respond to a panel of 40 antibiotics. The researchers have been testing their new platform using clinical data from around 60 cases of infections. They found that deploying their AI platform would have helped physicians to select specialized antibiotics over broad-spectrum ones in 89 percent of the cases.

The platform “may thus be an important new tool for treatment optimization and antibiotic stewardship,” wrote the authors.

About the Author
PhD
Interested in health technology and innovation.
You May Also Like
MAY 02, 2022
Clinical & Molecular DX
A Lyme Disease Vaccine Could be Available Soon
MAY 02, 2022
A Lyme Disease Vaccine Could be Available Soon
There is currently no vaccine available to prevent Lyme disease, a tick-borne illness prevalent across the United States ...
MAY 09, 2022
Clinical & Molecular DX
COVID-19 Vaccine Technique Guiding Heart Disease Research
MAY 09, 2022
COVID-19 Vaccine Technique Guiding Heart Disease Research
The heart is made up in part of cardiomyocytes, specialized cells responsible for controlling heart beats. After a heart ...
MAY 10, 2022
Immunology
A Failed Immunotherapy Trial Leads to a Crucial Discovery
MAY 10, 2022
A Failed Immunotherapy Trial Leads to a Crucial Discovery
Immunotherapies, which boost a patient's immune system so it's better at fighting cancer, have been a game-chang ...
MAY 12, 2022
Clinical & Molecular DX
Researchers Show Influenza Directly Infects the Heart
MAY 12, 2022
Researchers Show Influenza Directly Infects the Heart
Heart complications are often observed in severe or fatal cases of Influenza. These problems can include electrical malf ...
MAY 13, 2022
Drug Discovery & Development
Multiple Mental Health Diagnoses are Increasingly Common. Why?
MAY 13, 2022
Multiple Mental Health Diagnoses are Increasingly Common. Why?
Mental illness has become increasingly common. The number of people with anxiety and depression, specifically, has stead ...
MAY 24, 2022
Technology
Sleepio the First Digital Therapeutic to Receive NICE Guidance for Insomnia Treatment
MAY 24, 2022
Sleepio the First Digital Therapeutic to Receive NICE Guidance for Insomnia Treatment
In a monumental moment for digital therapeutics, the National Institute for Health and Care Excellence (NICE) in the Uni ...
Loading Comments...